Overview of Dr. Lee
Dr. Benjamin Lee is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Queens. He received his medical degree from New York Medical College and has been in practice 15 years. He is one of 27 doctors at New York-Presbyterian Queens and one of 143 doctors at New York-Presbyterian Hospital who specialize in Thoracic Surgery. He has more than 40 publications and over 500 citings.
Office
525 E 68th St
# M404
New York, NY 10065Fax+1 646-962-0203
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Thoracic Surgery, 2007 - 2009
University of California Davis HealthResidency, Surgery, 2001 - 2007
New York Medical CollegeClass of 2001
Certifications & Licensure
CA State Medical License 2003 - Present
NY State Medical License 2007 - 2026
FL State Medical License 2017 - 2019
NJ State Medical License 2009 - 2017- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Clinical Trials
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Start of enrollment: 2007 Oct 12
Publications & Presentations
PubMed
- 129 citationsMachine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography an...Subhi J. Al'Aref, Gabriel Maliakal, Gurpreet Singh, Alexander R. van Rosendael, Xiaoyue Ma
European Heart Journal. 2020-01-14 - 163 citationsNeoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trialNasser K. Altorki, Timothy E. McGraw, Alain C. Borczuk, Ashish Saxena, Jeffrey L. Port
The Lancet. Oncology. 2021-06-01 - 46 citationsNodal Upstaging in Robotic and Video Assisted Thoracic Surgery Lobectomy for Clinical N0 Lung Cancer.Benjamin Lee, Mark Shapiro, John R. Rutledge, Robert J. Korst
The Annals of Thoracic Surgery. 2015-07-01
Press Mentions
Surgical Resection After Neoadjuvant Durvalumab and Radiation Is Feasible and Safe in Non-Small Cell Lung Cancer: Results from a Randomized TrialMay 17th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
